Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00499096 · ClinicalTrials.gov registry record · Phase 3
Self-Management Addressing Heart Disease Risk Trial
A Phase 3 study of Bipolar Disorder and Cardiovascular Disease, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 3
- Development phase
- 118
- Enrollment target
- 1
- Study location
NCT00499096: Completed Phase 3 study of Bipolar Disorder and Cardiovascular Disease, sponsored by US Department of Veterans Affairs.
NCT00499096 is a Phase 3 study of Bipolar Disorder and Cardiovascular Disease that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 118 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00499096, a Phase 3 study of Bipolar Disorder and Cardiovascular Disease, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 118 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to learn whether or not people with bipolar disorder can reduce their risk of heart disease and related conditions by having a Care Manager provide self management and care management.
Primary Outcome
24-month systolic and diastolic blood pressure (mm/Hg): lower is better
Conditions Studied
Interventions
- BEHAVIORAL Chronic care model for Bipolar Disorder
Study Locations (1)
Michigan
- VA Ann Arbor Healthcare System - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2008-05 |
| Est. Completion | 2012-11 |
| Phase | Phase 3 |
What the finished NCT00499096 record still lists
NCT00499096 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (64% lower).
The record links to 2 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 1 intervention - of which Chronic care model for Bipolar Disorder is the first listed.
NCT00499096 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT00499096 about?
NCT00499096 is a clinical study titled "Self-Management Addressing Heart Disease Risk Trial". The purpose of this research study is to learn whether or not people with bipolar disorder can reduce their risk of heart disease and related conditions by having a Care Manager provide self management and care management.
What is the current status of trial NCT00499096?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 118 participants. The study started on 2008-05. Estimated completion is 2012-11.
What conditions does trial NCT00499096 study?
This clinical trial studies the following conditions: Bipolar Disorder, Cardiovascular Disease.
What interventions are being tested in trial NCT00499096?
The interventions under investigation include: Chronic care model for Bipolar Disorder (BEHAVIORAL).
Who is sponsoring clinical trial NCT00499096?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00499096 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00499096's enrollment target sits among peer trials
118 58th of 162 higher than 104 of 162 other Bipolar Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bipolar Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
RECRUITING · Phase 3
-
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
RECRUITING · Phase 3
-
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
RECRUITING · Phase 3
-
Study of Aripiprazole (Abilify) in Children With Symptoms of Mania
COMPLETED · Phase 3
-
Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression
COMPLETED · Phase 3
-
Acute Treatment of Bipolar II Depression
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia